NCT05996016 Gut and Vaginal Microbiota Profile Study for HIV Women
| NCT ID | NCT05996016 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Peking Union Medical College Hospital |
| Condition | HPV |
| Study Type | OBSERVATIONAL |
| Enrollment | 400 participants |
| Start Date | 2017-01-01 |
| Primary Completion | 2029-01-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 400 participants in total. It began in 2017-01-01 with a primary completion date of 2029-01-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Women Living with HIV Infection （WLHIV）are intended to acquire HPV infection which usually contributes to variable cervical lesions. we hypothesize that vaginal microbiota imbalance may make WLHIV prone to HPV infection，thereafter results in severe cervical lesion.
Eligibility Criteria
Inclusion Criteria: * HIV women （including pregnant）; * sign consent paper Exclusion Criteria: * virgin or maiden
Contact & Investigator
Wei Lyu, MD
PRINCIPAL INVESTIGATOR
No. 10Yi，Chaowai Street ，Chaoyang District ，Beijing ，China
Frequently Asked Questions
Who can join the NCT05996016 clinical trial?
This trial is open to female participants only, aged 14 Years or older, studying HPV. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05996016 currently recruiting?
Yes, NCT05996016 is actively recruiting participants. Contact the research team at lvweipumch@163.com for enrollment information.
Where is the NCT05996016 trial being conducted?
This trial is being conducted at Beijing, China.
Who is sponsoring the NCT05996016 clinical trial?
NCT05996016 is sponsored by Peking Union Medical College Hospital. The principal investigator is Wei Lyu, MD at No. 10Yi，Chaowai Street ，Chaoyang District ，Beijing ，China. The trial plans to enroll 400 participants.